American Heart News - Heart News
MARCH 5, 2024
Research Highlights: An analysis of health data in the UK Biobank found a 20% higher risk of irregular heart rhythm, known as atrial fibrillation, among people who said they drank two liters or more per week (about 67 ounces) of artificially sweetened.
Med Page Today
MARCH 5, 2024
(MedPage Today) -- Overconsumption of beverages with added sugar or artificial sweetener, already associated with several cardiometabolic diseases, showed new links to atrial fibrillation (Afib or AF) in a prospective cohort study. Within the.
Cardiology Update
MARCH 5, 2024
In the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial, researchers examined the risk of ischemic events in patients with stable coronary artery disease. The study evaluated outcomes associated with an invasive strategy involving angiography and percutaneous coronary intervention (PCI) or surgical coronary artery bypass grafting (CABG), compared to a conservative strategy involving initial medical therapy.
Frontiers in Cardiovascular Medicine
MARCH 5, 2024
Background Previous studies have shown that global constructive work (CW) and wasted work (WW) predict response to cardiac resynchronization therapy (CRT). This study evaluated the predictive value of regional CW and WW for reverse remodeling and clinical outcomes after CRT. Methods We performed a prospective study involving 134 CRT candidates with left bundle branch block and left ventricular ejection fraction ≤35%.
DAIC
MARCH 5, 2024
February was a short but busy month in the diagnostic and interventional cardiology world, with a lot of news being generated and clinical trial data released. Here is a look at last month's Top 10. 1. Ismail El-Hamamsy, MD, PhD, Named President of the Heart Valve Society 2. ISC 2024 Late-breaking Science Finding from ZODIAC Study: Position of Head Before Surgery May Improve Stroke Patient’s Neurological Function 3.
HCPLive
MARCH 5, 2024
The FDA has greenlit Dexcom's Stelo Glucose Biosensor System, marking a historic first as the first continuous glucose monitors to be available over-the-counter.
Science Daily - Heart Disease
MARCH 5, 2024
Coronary artery calcium scoring with CT can identify symptomatic patients with a very low risk of heart attacks or strokes. Researchers said the findings may one day help some patients with stable chest pain avoid invasive coronary angiography.
Cardiovascular Update brings together the best content for cardiovascular medicine professionals from the widest variety of industry thought leaders.
DAIC
MARCH 5, 2024
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision. Other benefits of cardiac PET include consistent, high-quality images, low radiation exposure and short acquisition protocols. It also provides quantification of myocardial blood flow and strong prognostic power.* But adopting cardiac PET can be a daunting task for hospitals, health systems and clinics, especially
HCPLive
MARCH 5, 2024
Results of a new analysis underscore the significance of sleep health in mitigating type 2 diabetes risk, revealing that even an optimal diet may not fully offset the negative impact of inadequate sleep.
Science Daily - Heart Disease
MARCH 5, 2024
Researchers have developed a new catheter-based device that combines two powerful optical techniques to image the dangerous plaques that can build up inside the arteries that supply blood to the heart. By providing new details about plaque, the device could help clinicians and researchers improve treatments for preventing heart attacks and strokes.
HCPLive
MARCH 5, 2024
Use of corticosteroids with supportive therapy reduced proteinuria but was associated with adverse effects and did not impact time to ESKD versus supportive therapy alone.
Med Page Today
MARCH 5, 2024
(MedPage Today) -- FDA approved the Agent drug-coated balloon (DCB) for coronary in-stent restenosis, making this the first DCB to make it to the U.S. market, manufacturer Boston Scientific announced. In people with stable chest pain, a coronary.
HCPLive
MARCH 5, 2024
Initiation of SGLT2 inhibitors reduced the risk of composite anemia outcomes, compared with GLP-1 RA, among patients with type 2 diabetes and CKD.
Frontiers in Cardiovascular Medicine
MARCH 5, 2024
Penetrating aortic ulcer (PAU) represents a subset of acute aortic syndromes characterized by high rupture risk and management challenges, particularly in elderly patients with significant comorbidities. This case report showcases a 75-year-old patient with a history of coronary artery bypass graft (CABG) and with multiple PAUs involving the aortic arch, deemed unfit for conventional open surgery.
HCPLive
MARCH 5, 2024
Patients who were naïve to adalimumab tended to switch to other targeted therapies, while those who had been previously treated with adalimumab were more likely to switch back to the reference product.
Frontiers in Cardiovascular Medicine
MARCH 5, 2024
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the United States. Data shows that social drivers of health (SDOH), including economic stability, racial/cultural identity, and community, have a significant impact on cardiovascular morbidity and mortality. LGBTQ+ (lesbian, gay, bisexual, transgender, queer, and other gender and sexual minority) patients face a variety of unique health risk factors and bear a disproportionate burden of CVD compared to cis-gender, he
HCPLive
MARCH 5, 2024
Novo Nordisk announced topline data from the FLOW trial indicate semaglutide 1.0 mg (Ozempic) was associated with a 24% reduction in risk of kidney disease-related events among individuals with type 2 diabetes and CKD compared to placebo therapy.
American College of Cardiology
MARCH 5, 2024
A 59-year-old woman with newly diagnosed nonobstructive coronary artery disease (CAD) presents to the sports cardiology clinic. She is a long-distance runner who has participated in numerous marathons over the previous 20 years.
Cardiovascular Diabetology
MARCH 5, 2024
Atrial fibrillation (AF) has been linked to an increased risk of cardiovascular death, overall mortality and heart failure in patients with type 2 diabetes mellitus (T2DM). The present study investigated the a.
Frontiers in Cardiovascular Medicine
MARCH 5, 2024
Chronic kidney disease (CKD) significantly increases cardiovascular risk and mortality, and the accumulation of uremic toxins in the circulation upon kidney failure contributes to this increased risk. We thus performed a screening for potential novel mediators of reduced cardiovascular health starting from dialysate obtained after hemodialysis of patients with CKD.
HCPLive
MARCH 5, 2024
In time for daylight savings time starting on March 10, sleep experts weigh in on the harms of the daylight savings transition, such as increased risks for cardiovascular events, car accidents, and mortality.
JAMA Cardiology
MARCH 5, 2024
This cohort study examines the use of cardiopulmonary exercise testing in evaluating patients with transthyretin amyloidosis.
HCPLive
MARCH 5, 2024
This analysis looked into whether rapid respiratory virus testing in patients with suspected acute respiratory infection was linked to such outcomes as antibiotic use decrease and hospitalization.
American College of Cardiology
MARCH 5, 2024
In this interview, Jonathan R. Weir-McCall, PhD, and Christopher M. Kramer, MD, FACC, discuss From JACC: National Trends in Coronary Artery Disease Imaging: Associations With Health Care Outcomes and Costs.
HCPLive
MARCH 5, 2024
Our February 2024 month in review spotlights news in IgAN identification and management as well as recent research about various factors impacting renal care outcomes in different patient populations.
DAIC
MARCH 5, 2024
During the upcoming Healthcare Information and Management Systems Society Global Conference and Exhibition, HIMSS24, experts from the world’s largest government agencies will convene to focus on the future of public healthcare and the regulation of artificial intelligence (AI) and other emerging trends. Greg Singleton, Chief Artificial Intelligence Officer (CAIO) at the U.S.
HCPLive
MARCH 5, 2024
In new topline results from the KARDIA-2 trial, zilebesiran added to standard-of-care antihypertensive treatments showed significant reductions in systolic blood pressure.
Journal of Cardiothoracic Surgery
MARCH 5, 2024
This study aimed to compare hospital and long-term clinical outcomes associated with various treatment methods for Stanford A type aortic intramural hematoma (IMH) to provide a reference for clinical decision-.
DAIC
MARCH 5, 2024
milla1cf Tue, 03/05/2024 - 11:58 March 5, 2024 — FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heart failure monitoring. The FIRE1 System is the first device designed to directly measure a patient’s volume status by measuring the largest vein in the body where most fluid is stored – the inferior vena cava (IVC) – to better manage heart failure.
HCPLive
MARCH 5, 2024
Our February 2024 month-in-review recaps research on Long COVID’s effect on sleep, Black older adults’ poor sleep quality being linked to executive function decline, among other findings.
American College of Cardiology
MARCH 5, 2024
The goal of the REMOVE trial was to compare the safety and efficacy of an intraoperative hemoadsorption device for patients undergoing cardiac surgery for infective endocarditis (IE).
HCPLive
MARCH 5, 2024
The decision was based on clinical studies demonstrating no clinically meaningful differences between the biosimilar and its reference product.
Frontiers in Cardiovascular Medicine
MARCH 5, 2024
Objective This study aimed to assess the diagnostic value of prenatal echocardiography for identifying transposition of the great arteries (TGA) during pregnancy and evaluating the associated outcomes. Methods We conducted a retrospective analysis of 121 prenatally diagnosed patients with TGA at our hospital between January 2012 and September 2022. This analysis included prenatal ultrasound, prenatal screening, clinical management and follow-up procedures.
HCPLive
MARCH 5, 2024
These mental health outcomes were seen among those with self-reported COPD and asthma, though not among individuals with objective diagnoses based on spirometry.
Journal of Cardiovascular Pharmacology
MARCH 5, 2024
Multimers of von Willebrand factor (VWF) play a critical role in various processes inducing morbidity and mortality in cardiovascular risk patients. With the ability to reduce VWF multimers, N-acetylcysteine (NAC) could reduce mortality in patients undergoing coronary catheterization or cardiac surgery. However, its impact in perioperative period has never been studied so far in regard of its potential cardiovascular benefits.
HCPLive
MARCH 5, 2024
People of increasing age and worse socioeconomic status were more likely to be unwilling-in-principle to participate in home-monitoring vision tests.
Cardiovascular Diabetology
MARCH 5, 2024
Recent guidelines propose N-terminal pro-B-type natriuretic peptide (NT-proBNP) for recognition of asymptomatic left ventricular (LV) dysfunction (Stage B Heart Failure, SBHF) in type 2 diabetes mellitus (T2DM.
Expert insights. Personalized for you.
140 
Let's personalize your content